[
 {
  "document": {
   "authors": "Thrishna",
   "contact_info": "thrishna@causalitybiomodels.com",
   "copyright": "Copyright \u00a9 2020 Fraunhofer Institute SCAI, All rights reserved",
   "description": "COVID Knowledge Curation project",
   "licences": "Private Ownership to Fraunhofer Institute SCAI",
   "name": "32187463.bel",
   "version": "2.0.0"
  }
 },
 {
  "definitions": [
   {
    "namespace": {
     "keyword": "CHEBI",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/chebi/chebi-20190708.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "PFAM",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/pfam/pfam-names-20181024.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "TAX",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/ncbi-taxonomy/ncbi-taxonomy-20200322.belns",
     "value_list": []
    }
   },
   {
    "namespace": {
     "keyword": "MESH",
     "type": "URL",
     "value": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mesh/mesh-names-20181007.belns",
     "value_list": []
    }
   },
   {
    "annotation": {
     "keyword": "Custom_Disease",
     "type": "LIST",
     "value": null,
     "value_list": [
      "COVID-19"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "PublicationType",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Editorial"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "PublicationStatus",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Preprint"
     ]
    }
   },
   {
    "annotation": {
     "keyword": "Section",
     "type": "LIST",
     "value": null,
     "value_list": [
      "Full Text"
     ]
    }
   }
  ]
 },
 {
  "statements_and_sets": [
   {
    "sets": [
     {
      "citation": {
       "type": "PubMed",
       "title": "N Engl J Med. 2020 Mar 18. doi: 10.1056/NEJMe2005477.",
       "ref": "32187463",
       "pub_date": "",
       "author_list": "",
       "comment": ""
      }
     },
     {
      "set": {
       "PublicationType": [
        "Editorial"
       ]
      }
     },
     {
      "set": {
       "PublicationStatus": [
        "Preprint"
       ]
      }
     },
     {
      "set": {
       "Section": [
        "Full Text"
       ]
      }
     },
     {
      "evidence": "One antiviral-drug candidate is a combination of the HIV protease \\\ninhibitors lopinavir and ritonavir."
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "composite"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "lopinavir"
          }
         ]
        ],
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "ritonavir"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "is_a"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "antiviral drug"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "lopinavir"
        }
       ]
      ]
     },
     {
      "relation": "is_a"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "HIV protease inhibitor"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "ritonavir"
        }
       ]
      ]
     },
     {
      "relation": "is_a"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "HIV protease inhibitor"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "Lopinavir, which acts against the viral 3CL protease, has modest \\\nantiviral activity against SARS-CoV-2.1"
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "lopinavir"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "protein"
        }
       },
       [
        {
         "namespace": "PFAM",
         "name": "Peptidase_C30"
        }
       ]
      ]
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "CHEBI",
         "name": "lopinavir"
        }
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "TAX",
         "name": "Severe acute respiratory syndrome coronavirus 2"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "evidence": "The number of deaths was somewhat lower in the group that received \\\nlopinavir\u2013ritonavir."
     },
     {
      "set": {
       "Custom_Disease": [
        "COVID-19"
       ]
      }
     }
    ]
   },
   {
    "statement": [
     {
      "subject": [
       {
        "function": {
         "type": "list",
         "name": "composite"
        }
       },
       [
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "lopinavir"
          }
         ]
        ],
        [
         {
          "function": {
           "type": "abundance",
           "name": "abundance"
          }
         },
         [
          {
           "namespace": "CHEBI",
           "name": "ritonavir"
          }
         ]
        ]
       ]
      ]
     },
     {
      "relation": "decreases"
     },
     {
      "object": [
       {
        "function": {
         "type": "abundance",
         "name": "abundance"
        }
       },
       [
        {
         "namespace": "MESH",
         "name": "Mortality"
        }
       ]
      ]
     }
    ]
   },
   {
    "sets": [
     {
      "unset": [
       "Custom_Disease"
      ]
     },
     {
      "unset": [
       "PublicationType"
      ]
     },
     {
      "unset": [
       "PublicationStatus"
      ]
     },
     {
      "unset": [
       "Section"
      ]
     },
     {
      "unset": [
       "Citation"
      ]
     }
    ]
   }
  ]
 }
]